bevacizumab,trifluridine tipiracil
roche,otsuka,taiho pharma
[]
great news for #coloncancer at #gi23 with sunlight trial. adding bevacizumab to tas-102 increases mos from 7.5 to 10.8 months. 
Husband, father of 3, physician-scientist, aspiring oncologist, transcriptional biologist, @VUMC_MedPSTP chief, views are my own